Health
Why do some patients develop COVID-19 pneumonia? – Drug Target Review
Some patients who develop severe COVID-19 symptoms mount ineffective immune responses due to a lack of type I interferons.
Posted: 28 September 2020 | Hannah Balfour (Drug Target Review) | No comments yet
Scientists reveal that some patients who develop severe COVID-19 symptoms mount ineffective immune responses due to a lack of type I interferons, either through genetic mutation or inactivation by auto-reactive antibodies.
The varied severity of COVID-19 symptoms in the population has puzzled and intrigued researchers since the start of the pandemic. Now, new findings could help explain why some people with COVID…
Continue Reading
